Keywords: trellis, bioscience, raises, million, privately-held, california, usa-based
Trellis Bioscience raises $10 million
Article | 19 February 2007
Trellis Bioscience, a privately-held, California, USA-based biotechnology company, has raised $10.0 million in a series B referred stock venture capital financing. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
